NTA provides a curated pipeline of vetted opportunities aligned with industry and national priorities. We are continuously consolidating new opportunities from Catalyst Partners, government requirements, and industry targets. Contact us to share your opportunities with NTA’s diverse community or organizations. Join NTA today to receive email notifications.
Upcoming
Vaccines Capability Area
Anticipated Release Date: Q3FY24 OR Q4FY24 Multiple Topics TBD—Possible 3 or 4 The goal of the Vaccines Capability Area is …
Accelerated Antibodies Modification
Anticipated Release Date: Q3FY24: Modification of existing Accelerated Antibodies agreement for additional monoclonal antibody prototype. Responding to this opportunity requires …
ChemDx Expansion
Anticipated Release Date: Q3FY24 Develop a diagnostic prototype strip, compatible with the ChemDx device, able to diagnose opioid exposure. Additional …
Development of Alternate Large Animal Models For Biothreats (Viral and Toxin) and Chemical Threats
Anticipated Release Date: Q4FY24 Development of alternate large animal models for biothreats (viral and toxin) and chemical threats. Due to …
Prototype MCMs to address the therapeutic indications of the Warfighter exposure to viral and bacterial biothreat agents
Anticipated Release Date: Q4FY24 The prioritizations on broad-spectrum direct-acting antivirals (nucleoside/nucleotide-like compounds and combination therapies) and host-directed broad-spectrum antivirals and …
Development of Novel, Broad Spectrum Countermeasures, and enabling capabilities for Toxin Exposure
Anticipated Release Date: Q4FY24 Prophylactic and therapeutic medical countermeasures for exposure to naturally occurring, synthetic and/or aerosolized toxins (excluding botulinum …
Mature Microphysiological System To Directly Compare To Well-Characterized Animal Model Results
Anticipated Release Date: Q4FY24 Develop a microphysiological system that realistically mimics human physiological responses to threat exposures for rapid discovery …
Therapeutics Capability Area
Anticipated Release Date: Q3FY24 OR Q4FY24 Multiple Topics TBD—Possible 3 or 4 The goal of the Therapeutics Capability Area is …
Shipboard Isolation System (SIS) / PPMT
Anticipated Release Date: Q4FY24 The SIS program provides the capability to temporarily isolate or quarantine personnel to prevent the spread …
Portable Patient Transport System -Enhanced Biodefense (PPTS-ENBD) / PPMT
Anticipated Release Date: Q4FY24 The Portable Patient Transport System Enhanced Biodefense (PPTS ENBD) is a patient transport system that enables …
IEW Phase 2
Anticipated Release Date: Q4FY24 Establish Mission Planning and integration of the tactical, operational, Network convergence and CI/CD pipeline. This will allow …
Command and Control (C2) for Collaborative Combat Aircraft
Anticipated Release Date: 10/18/24 This RFS will be issued to address the need of Naval Surface Warfare Center (NSWC) Crane …
Consolidated Nerve Agent Treatment System
Anticipated Release Date: Q1FY25 FDA approval of a multi-drug autoinjector to reduce logistical burden on the warfighter and increase survivability …
Agent Directed Therapeutic (ADTX) FY25 OTA
Anticipated Release Date: Q1FY25 New start OTA award for ADTX Responding to this opportunity requires membership in the Countering Weapons …
Autonomous Decontamination System (ADS) / PPMT
Anticipated Release Date: Q1FY25 The Autonomous Decontamination System program will provide a semi-autonomous supported capability that relies on precision detection …
VADER VaporAgent Demasking –Easily Readable
Anticipated Release Date: Q2FY25 VaporAgent Demasking –Easily Readable Develop low-burden, low-cost detection capabilities for chemical threat vapors to facilitate doffing …
Systems Integrating iNnovativeSolutions To Enable Rapid detection (SINISTER)
Release Date: Q2FY25 Develop novel multi-functional detection indicator technology for vapor and aerosol hazards aimed at decreasing burden via easy-to-use SWaP-C …
Novelbioaerosol Detection and Identification Technologies
Anticipated Release Date: Q2FY25 Novel approaches to bioaerosol detection and identification that implement reliable, accurate and timely sampling mechanisms in a …
Diagnostic Platforms for Agnostictoxin Detections
Anticipated Release Date: Q2FY25 Develop diagnostic and detection assays, platforms, or devices to sense exposures of emerging toxins, to include …
Portable Patient Transport System – Enhanced Biodefense, PPTS-ENBD
Anticipated Release Date: Q3FY25 PPTS-ENBD will provide a biocontainment isolation system to safely transport personnel infected or suspected of infection …
Shipboard Isolation System (SIS)
Anticipated Release Date: Q3FY25 SIS will provide the capability to temporarily isolate or quarantine personnel to prevent the spread of …
Biocontainment Isolation System – Enhanced Biodefense (BCIS-ENBD)
Anticipated Release: Q3FY25 BCIS-ENBD will provide a ground-based isolation area for personnel infected or suspected of infection of biological organism …
Synthetic Binder Prediction, Synthesis, and Assay Development
Anticipated Release: Q3FY25 This effort will solicit multidisciplinary teams for a competition involving prediction of synthetic binders, synthesis of identified …
Capabilities and Needs for Future Respiratory and Ocular Protection Systems
Anticipated Release Date: Q3FY25 This topic aims to provide novel, low-burden masks for the general purpose warfighter utilizing innovative materials …
CIND, All States of Matters For Various Chemical Hazards
Anticipated Release: Q4FY25 Chemical indicators; Low-cost, easy to use, ultra-low SWaP modular open system based chemical detector that is widely …
CBRN Sensor Integration On Robotic Platforms (CSIRP) Capability Set (CS) 4.0
Anticipated Release: Q4FY25 The Government is seeking proposals for development and integration of new CBRN sensing payloads, using common interfaces, …
Far Forward Biological Sequencing (FFBS), Increment 2
Anticipated Release: Q1FY26 FFBS Increment 2 will focus on automating the sample preparation process and meeting any key performance parameter …
Advanced System for Protection and Integrated Reduction of Encumbrances, ASPIRE
Anticipated Release Date: Q3FY26 ASPIRE will provide respiratory and ocular protection against Chemical, Biological, Radiological and Nuclear threats that allows …
Advanced Differential Diagnostics (ADD)
Anticipated Release: Q4FY27 Host response based test to predict illness severity. Responding to this opportunity requires membership in the Countering …
Active
Ecology and Evolution of Infectious Diseases
Due: November 20, 2024 The multi-agency Ecology and Evolution of Infectious Diseases program supports research on the ecological, evolutionary, organismal, …
Development of an Expeditionary Medical (EXMED) mobile Command, Control, Communications, and Computers IT (C4IT) solution for integration into Expeditionary Fast Transport (T-EPF) Flight II
Due: November 25, 2024 This RPP is focused on development of expeditionary medical (EXMED) command and control (C2), communications, and …
Archaeometry
Due: December 2, 2024 The goal of this effort is to fund projects in two main categories: 1) to develop …
Halting Tuberculosis (TB) Transmission
Due: December 4, 2024 The purpose of this notice of funding opportunity (NOFO) is to understand the critical drivers of …
DoD Combat Readiness – Medical, Translational Research Award
Due: December 5, 2024 The intent of the FY24 CRRP TRA is to support high-impact translational research that will accelerate …
White-nose Syndrome Research for Conservation Grants – 2024
Due: December 15, 2024 The U.S. Fish and Wildlife Service (Service) makes funding available for research and conservation action to …
Seeking Innovations to Renew and Strengthen Fibers during washing clothes
Due: December 30, 2024 Desired outcome The world leader in Laundry Products is looking for innovative technologies to be incorporated …
Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models
Due: January 5, 2025 This funding opportunity announcement (FOA) encourages applications from small business concerns (SBCs) for Small Business Innovation …
Single Blood Donor Collection and Storage Bags Manufactured in Continental United States
Due: January 6, 2025 In accord with the Department of Defense (DoD) 2022 National Defense Strategy identifying Building Enduring Advantages, …
Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer
Due: January 7, 2025 The purpose of this Funding Opportunity Announcement (FOA) is to support basic research that elucidates mechanisms …
Targeting Inflammasomes in HIV and Substance Use
Due: March 13, 2025 The scientific objective of this Funding Opportunity Announcement is to encourage research to delineate the role …
Scalable Solutions Office: Office-Wide Innovative Solutions Opening for Advanced Research Projects Agency for Health
Due: March 14, 2025 This ISO seeks solution summaries and proposals for projects that fall within the general scope of …
Mathematical Foundations of Digital Twins
Due: March 17, 2025 The Division of Mathematical Sciences (DMS) in the Directorate for Mathematical and Physical Sciences (MPS) at …
Expeditions in Computing
Due: March 31, 2025 The far-reaching impact and rate of innovation in the computer and information science and engineering fields …
NSF National Quantum Virtual Laboratory – Quantum Testbeds
Due: April 1, 2025 The National Quantum Initiative (NQI) Act1aims to ensure the continuing leadership of the United States (U.S.) …
Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications
April 25, 2025 This Notice of Funding Opportunity Announcement (NOFO), issued by the National Institutes of Health (NIH) and the …
Industrialization and Translation of Extracellular Vesicles For Use In Regenerative Medicine
DUE: June 7, 2025 STTR Opportunity: Supporting the development of extracellular vesicle technologies for regenerative medical applications APPLY …
Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 Clinical Trials Not Allowed)
DUE: June 25, 2025 SBIR Opportunity: Supporting the development of extracellular vesicle technologies for regenerative medical applications. APPLY …
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products
Due: July 14, 2026 This Notice of Funding Opportunity (NOFO) encourages cooperative agreement applications for investigator-initiated, multi-site, clinical trials (Phase …
Grant Opportunity: Research Projects to Enhance Applicability of Mammalian Models for Translational Research
DUE: September 7, 2026 The National Cancer Institute invites applications for projects to expand, improve, or transform the utility of …
Grant Opportunity: Assay development and screening for discovery of chemical probes, drugs or immunomodulators
DUE: September 7, 2026 Seeking applications for identification of small molecules that function to elucidate the biology of disease as …
Grant Opportunity: Personal Health Informatics for Delivering Actionable Insights to Individuals
DUE: November 5, 2026 Furthering the science of personal health informatics by providing meaningful and actionable insights to individuals through …
Grant Opportunity: Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics
DUE: January 7, 2027 Funding available to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics …
Grant Opportunity: Improving Diagnostic Safety in Ambulatory Care
DUE: August 31, 2028 Funding opportunity to develop strategies and interventions to improve diagnostic safety in the heterogenous ambulatory care …
AHRQ Health Services Research Projects
Due: October 6, 2029 The purpose of this Notice of Funding Opportunity (NOFO) is to seek health services research grant …